Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial” - Sung Hwan Lee; Sun Young Yim; Ji Hoon Kim; Sunyoung S. Lee; Ahmed O. Kaseb; Ju-Seog Lee (Clinical and Molecular Hepatology)